Details for Patent: 6,756,393
Summary for Patent: 6,756,393
| Title: | Azacyclic compounds |
| Abstract: | Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment. |
| Inventor(s): | Carl-Magnus A. Andersson, Glenn Croston, Eva L. Hansen, Allan Kjaersgaard Uldam |
| Assignee: | Acadia Pharmaceuticals Inc |
| Application Number: | US10/409,782 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,756,393 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 6,756,393
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,756,393
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 348808 | ⤷ Start Trial | |||
| Australia | 2005202257 | ⤷ Start Trial | |||
| Australia | 4007201 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
